Bard Associates’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,600
| Closed | -$337K | – | 177 |
|
|
2023
Q4 | $337K | Sell |
14,600
-4,500
| -24% | -$104K | 0.13% | 134 |
|
|
2023
Q3 | $153K | Sell |
19,100
-11,574
| -38% | -$92.5K | 0.06% | 165 |
|
|
2023
Q2 | $267K | Hold |
30,674
| – | – | 0.1% | 148 |
|
|
2023
Q1 | $90.2K | Hold |
30,674
| – | – | 0.04% | 176 |
|
|
2022
Q4 | $107K | Sell |
30,674
-2,350
| -7% | -$8.23K | 0.05% | 172 |
|
|
2022
Q3 | $261K | Hold |
33,024
| – | – | 0.12% | 141 |
|
|
2022
Q2 | $260K | Buy |
33,024
+8,270
| +33% | +$65.1K | 0.11% | 144 |
|
|
2022
Q1 | $301K | Hold |
24,754
| – | – | 0.11% | 149 |
|
|
2021
Q4 | $303K | Hold |
24,754
| – | – | 0.1% | 147 |
|
|
2021
Q3 | $258K | Buy |
24,754
+1,750
| +8% | +$18.2K | 0.09% | 152 |
|
|
2021
Q2 | $207K | Buy |
+23,004
| New | +$207K | 0.07% | 155 |
|
|
2020
Q4 | – | Sell |
-6,715
| Closed | -$35K | – | 154 |
|
|
2020
Q3 | $35K | Sell |
6,715
-1,575
| -19% | -$8.21K | 0.02% | 148 |
|
|
2020
Q2 | $63K | Buy |
8,290
+350
| +4% | +$2.66K | 0.04% | 148 |
|
|
2020
Q1 | $81K | Sell |
7,940
-140
| -2% | -$1.43K | 0.06% | 139 |
|
|
2019
Q4 | $125K | Sell |
8,080
-300
| -4% | -$4.64K | 0.06% | 145 |
|
|
2019
Q3 | $152K | Sell |
8,380
-408
| -5% | -$7.4K | 0.08% | 145 |
|
|
2019
Q2 | $144K | Sell |
8,788
-30
| -0.3% | -$492 | 0.07% | 145 |
|
|
2019
Q1 | $158K | Sell |
8,818
-138
| -2% | -$2.47K | 0.08% | 146 |
|
|
2018
Q4 | $169K | Sell |
8,956
-150
| -2% | -$2.83K | 0.1% | 145 |
|
|
2018
Q3 | $325K | Hold |
9,106
| – | – | 0.15% | 133 |
|
|
2018
Q2 | $189K | Sell |
9,106
-50
| -0.5% | -$1.04K | 0.09% | 148 |
|
|
2018
Q1 | $112K | Buy |
9,156
+940
| +11% | +$11.5K | 0.06% | 158 |
|
|
2017
Q4 | $89K | Sell |
8,216
-230
| -3% | -$2.49K | 0.04% | 159 |
|
|
2017
Q3 | $101K | Sell |
8,446
-560
| -6% | -$6.7K | 0.05% | 161 |
|
|
2017
Q2 | $154K | Sell |
9,006
-100
| -1% | -$1.71K | 0.07% | 163 |
|
|
2017
Q1 | $157K | Sell |
9,106
-1,005
| -10% | -$17.3K | 0.07% | 159 |
|
|
2016
Q4 | $173K | Sell |
10,111
-320
| -3% | -$5.48K | 0.08% | 150 |
|
|
2016
Q3 | $314K | Sell |
10,431
-130
| -1% | -$3.91K | 0.15% | 128 |
|
|
2016
Q2 | $299K | Sell |
10,561
-620
| -6% | -$17.6K | 0.16% | 126 |
|
|
2016
Q1 | $300K | Buy |
11,181
+4,000
| +56% | +$107K | 0.17% | 127 |
|
|
2015
Q4 | $346K | Sell |
7,181
-100
| -1% | -$4.82K | 0.2% | 116 |
|
|
2015
Q3 | $266K | Hold |
7,281
| – | – | 0.15% | 122 |
|
|
2015
Q2 | $274K | Sell |
7,281
-150
| -2% | -$5.65K | 0.14% | 128 |
|
|
2015
Q1 | $294K | Sell |
7,431
-120
| -2% | -$4.75K | 0.14% | 131 |
|
|
2014
Q4 | $310K | Hold |
7,551
| – | – | 0.14% | 137 |
|
|
2014
Q3 | $334K | Sell |
7,551
-37
| -0.5% | -$1.64K | 0.16% | 136 |
|
|
2014
Q2 | $329K | Sell |
7,588
-300
| -4% | -$13K | 0.13% | 157 |
|
|
2014
Q1 | $323K | Hold |
7,888
| – | – | 0.14% | 152 |
|
|
2013
Q4 | $328K | Sell |
7,888
-200
| -2% | -$8.32K | 0.14% | 153 |
|
|
2013
Q3 | $332K | Sell |
8,088
-250
| -3% | -$10.3K | 0.15% | 148 |
|
|
2013
Q2 | $323K | Buy |
+8,338
| New | +$323K | 0.15% | 143 |
|